From the Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, Texas.

Corresponding author: Douglas D. Koch, MD, Cullen Eye Institute, Baylor College of Medicine, 6565 Fannin St, NC 205, Houston, TX 77030. Email: [email protected].

Supported in part by the SRB Charitable Corp., Fort Worth, Texas; the Sid W. Richardson Foundation, Fort Worth, Texas (Kozhaya, Wang, Weikert, Koch); and an unrestricted grant from Research to Prevent Blindness, New York, New York (Wang, Weikert, Koch).

Disclosures: L. Wang is a consultant for Carl Zeiss Meditec AG, Acufocus, Inc., Cassini Technologies, and Alcon Laboratories, Inc. D.D. Koch is a consultant for Alcon Laboratories, Inc., Bausch & Lomb, Inc., Carl Zeiss Meditec AG, and Johnson & Johnson Vision. M.P. Weikert is a consultant for Alcon Laboratories, Inc. and Carl Zeiss Meditec AG. The remaining author has no financial or proprietary interest in any material or method mentioned.

First author:Karim Kozhaya, MDDepartment of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, Texas